KLK-B1 anticorps
Aperçu rapide pour KLK-B1 anticorps (ABIN630229)
Antigène
Reactivité
Hôte
Clonalité
Application
-
-
Purification
- Purified
-
Immunogène
- KLK-B1 antibody was raised using a synthetic peptide corresponding to a region with amino acids VLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVS
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KLK-B1 Blocking Peptide, (ABIN5614387), is also available for use as a blocking control in assays to test for specificity of this KLK-B1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KLKB1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KLK-B1
-
Sujet
- Plasma prekallikrein is a glycoprotein that participates in the surface-dependent activation of blood coagulation, fibrinolysis, kinin generation and inflammation. It is synthesized in the liver and secreted into the blood as a single polypeptide chain. Plasma prekallikrein is converted to plasma kallikrein by factor XIIa by the cleavage of an internal Arg-Ile bond. Plasma prekallikrein deficiency causes a prolonged activated partial thromboplastin time in patients.
-
Poids moléculaire
- 28 kDa (MW of target protein)
Antigène
-